カレントテラピー 31-2サンプル

カレントテラピー 31-2サンプル page 12/34

電子ブックを開く

このページは カレントテラピー 31-2サンプル の電子ブックに掲載されている12ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要:
治療抵抗性高血圧の原因と治療対策2)La Batide-Alanore A, Chatellier G, Bobrie G, et al:Comparisonof nurse - and physician -determined clinic blood pressurelevels in patients referred to a hypertension....

治療抵抗性高血圧の原因と治療対策2)La Batide-Alanore A, Chatellier G, Bobrie G, et al:Comparisonof nurse - and physician -determined clinic blood pressurelevels in patients referred to a hypertension clinic:implications for subsequent management. J Hypertens 18:391 -398, 20003)Kuwajima I, Hoh E, Suzuki Y, et al:Pseudohypertension inthe elderly. J Hypertens 8:429-432, 19904)Pierdomenico SD, Lapenna D, Bucci A, et al:Cardiovascularoutcome in treated hypertensive patients with responder,masked, false resistant, and true resistant hypertension. AmJ Hypertens 18:1422 -1428, 20055)de la Sierra A, Segura J, Banegas JR, et al:Clinical featuresof 8295 patients with resistant hypertension classified on thebasis of ambulatory blood pressure monitoring. Hypertension57:898 -902, 20116)Muxfeldt ES, Fiszman R, de Souza F, et al:Appropriatetime interval to repeat ambulatory blood pressure monitoringin patients with white -coat resistant hypertension.Hypertension 59:384-389, 20127)Verdecchia P, Reboldi GP, Angeli F, et al:Short- and longtermincidence of stroke in white -coat hypertension. Hypertension45:203-208, 20058)Mancia G, Facchetti R, Bombelli M, et al:Long-term risk ofmortality associated with selective and combined elevation inoffice, home, and ambulatory blood pressure. Hypertension47:846 -853, 20069)Grassi G, Seravalle G, Trevano FQ, et al:Neurogenic abnormalitiesin masked hypertension. Hypertension 50:537 -542,200710)Yano Y, Kario K:Nocturnal blood pressure and cardiovasculardisease:a review of recent advances. Hypertens Res35:695-701, 201211)Fan HQ, Li Y, Thijs L, et al:International Database onAmbulatory Blood Pressure In Relation to CardiovascularOutcomes Investigators:Prognostic value of isolated nocturnalhypertension on ambulatory measurement in 8711 individualsfrom 10 populations. J Hypertens 28:2036 -2045,201012)Muxfeldt ES, Cardoso CR, Salles GF:Prognostic value ofnocturnal blood pressure reduction in resistant hypertension.Arch Intern Med 169:874-880, 200913)Nasothimiou EG, Tzamouranis D, Rarra V, et al:Diagnosticaccuracy of home vs. ambulatory blood pressure monitoringin untreated and treated hypertension. Hypertens Res 35:750 -755, 201214)Nasothimiou EG, Tzamouranis D, Roussias LG, et al:Homeversus ambulatory blood pressure monitoring in the diagnosisof clinic resistant and true resistant hypertension. J HumHypertens. 2011 Nov 10. doi:10.1038/jhh.2011.98.[Epubahead of print]15)Hanninen MR, Niiranen TJ, Puukka PJ, et al:Prognostic significanceof masked and white-coat hypertension in the generalpopulation:the Finn -Home Study. J Hypertens 30:705-712, 201216)Bobrie G, Chatellier G, Genes N, et al:Cardiovascular prognosisof "masked hypertension" detected by blood pressureself -measurement in elderly treated hypertensive patients.JAMA 291:1342 -1349, 200417)Pickering TG, White WB;American Society of HypertensionWriting Group:ASH Position Paper:Home and ambulatoryblood pressure monitoring. When and how to use self(home)and ambulatory blood pressure monitoring. J Clin Hypertens(Greenwich)10:850-855, 2008Current Therapy 2013 Vol.31 No.212715